AI judging. Sports betting. Fantasy sports. And soon, a year-round, team-based league format. It’s a brave new world for X Games, and under majority owner MSP Sports Capital and new CEO Jeremy ...

While the ABB FIA Formula E World Championship is just 10 full seasons old ... Safety improvements were built into the new car in the form of the FIA-mandated halo device and ATTACK MODE added an ...

Hint: The basic equation of a circle is x^2 + y^2 = r^2 ... Two elements A[i] and A[j] form an inversion if A[i] > A[j] but i < j. That is, a smaller element appears after a larger element. Given an ...

Vertex just won approval for a drug to treat one of the most common health problems -- pain. The biotech company is offering an option for patients and doctors who don’t want to go for ...

In a report released yesterday, Liisa Bayko from Evercore ISI maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), with ...

The FDA recently approved Journavx for treating acute pain. This approval is tremendously important for Vertex Pharmaceuticals. The biotech company has also received other good news over the last ...

UnitedHealthcare likely to cover Vertex’s pain drug Vertex Pharmaceuticals received FDA approval for a new non-opioid pain drug, marketed as Journavx, and it appears the nation’s largest ...

From packable sleeping pads to ultracomfortable air beds, we tested and found the best camping mattresses and sleeping pads ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Next: Access Our New, Shockingly Simple 'Alert System' RBC Capital Markets says Vertex management is optimistic about the recently approved Alyftrek. They predict that most of the 6,000 patients ...

Vertex has been running a number of trials because if there’s one thing that we can take away from the failed drug development projects of the past, it’s that there are many kinds of pain.